Andrew Adamovich

Andrew Adamovich has a diverse work experience spanning several industries. Andrew began their career as an Analyst at Peregrine Investments in 1997 before moving on to Zurich Centre Group as an Associate in 1998. In 2003, they joined Equity Partners Asia Limited as a Director, where they worked until 2005. Andrew then became the Managing Director of Riverland Capital Limited in 2005, a position they held until November 2020. In 2008, they became a Director and Shareholder at Yuan Chuan Radio Advertising, where they worked until April 2016. Additionally, from 2004 onwards, they have been a Director and Acting Chairman at G2 Therapies Pty Ltd. More recently, Andrew has held the role of Non Executive Director at CGI Glass Lewis Pty. Limited since January 2021. Their most recent position is the Chief Executive Officer of AdvanCell Isotopes Pty Ltd, a role they assumed in August 2022.

Andrew Adamovich attended the German Swiss International School in Hong Kong from 1982 to 1990. Andrew then went on to study at Phillips Academy from 1990 to 1992. Finally, they obtained a BA degree in English and History from the University of California, Berkeley from 1992 to 1997.